ALBANY,
New York, August 25, 2014 – The global cytogenetics market will
be valued at US$1.9 billion in the year 2019, after growth at a CAGR
of 23.4% from 2013 to 2019, according to the report by Transparency
Market Research. The market was worth US$468.2 million in 2019.
The research report titled “Molecular Cytogenetics Market (Technologies: FISH and aCGH; Applications: Genetic Disorders, Cancer and Personalized Medicine) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019”, is aimed at establishing the importance of the upcoming technologies in molecular cytogenetics, namely FISH and aCGH.
For
further information about the research report regarding the ToC and
analysis details, please visit:
http://www.transparencymarketresearch.com/molecular-diagnostics-market.html.
The report states that the array Comparative Genomic Hybridization (aCGH) market is expected to be a fast-growing sector, registering a CAGR of 20%. aCGH is a technique that utilizes a high resolution tool incorporating thousands of experiments in one array. This means that clinicians can shift from sequential diagnosis to parallel diagnosis, allowing them to conduct experiments with accurate results at one time.
The
report explains that Fluorescence In Situ Hybridization (FISH)
technology is attributed to interpret information at the genome
level, and currently dominates the molecular cytogenetics market.
Over the past decade, the FISH technology has been used to identify
various diseases as well as suggest accurate treatment. The technique
is being constantly improved by work in the field of bioinformatics
and genomics.
According
to the report, aCGH is a more accurate technique, and is expected to
surpass FISH in the next few years. The increase in demand for a
better cytogenetic technique should be successfully met by expansions
in manufacturer product portfolios.
The
report also provides an exhaustive and comparative analysis of the
key players in the industry: Agilent Technologies, Inc., Abbott
Laboratories, Affymetrix, Inc., Bio-Rad Laboratories, BI Biological
Industries, Illumina, Inc., Cytognomix, Inc., CytoTest, Inc., Inc.,
Hoffmann-La Roche Ltd., Life Technologies Corporation, LEICA
BIOSYSTEMS, PerkinElmer, Inc., Oxford Gene Technology, Applied
Spectral Imaging, Inc., and SciGene Corporation.
The
report predominantly explores the molecular cytogenetics market using
three categorical segregations. On the basis of technology, the
report analyzes FISH and aCGH. The various applications documented in
the report include cancer, genetic disorders, personalized medicines,
and others. By geography, the report focuses on North America,
Europe, Asia-Pacific, and Rest of the World.
The
report utilizes Porter’s Five Force Analysis to create a
comparative landscape of the market from the standpoint of both
buyers and suppliers, as well as threat from competitors,
substitutes, and new entrants.
About
Us
Transparency
Market Research is a market intelligence company providing global
business information reports and services. Our exclusive blend of
quantitative forecasting and trends analysis provides forward-looking
insight for thousands of decision makers.
We
are privileged with highly experienced team of Analysts, Researchers
and Consultants, who use proprietary data sources and various tools
and techniques to gather, and analyze information. Our business
offerings represent the latest and the most reliable information
indispensable for businesses to sustain a competitive edge.
Contact
Transparency
Market Research
90
State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA
- Canada Toll Free 866-552-3453
No comments:
Post a Comment